申请人:Boehringer Mannheim GmbH
公开号:US04113871A1
公开(公告)日:1978-09-12
Phenyl-alkane-carboxylic acids of the formula ##STR1## wherein A is an aryl, aralkyl or arylvinyl radical optionally substituted by hydroxy, halogen, trifluoromethyl, alkyl, alkylthio, alkoxy, alkenyloxy, alkoxyalkoxy, alkyl-substituted amino, aryloxy or alkoxy-substituted aryloxy, or is an aryloxyalkyl or arylthioalkyl radical, or a heterocyclic ring system optionally substituted by halogen, alkyl or alkoxy, Y is a valency bond or an unbranched or branched lower alkylene radical containing up to 3 carbon atoms, X is a straight or branched, saturated or unsaturated divalent aliphatic hydrocarbon radical containing 2 to 8 carbon atoms, there being at least 2 carbon atoms between the benzene ring and the carboxyl group, and R is a hydrogen atom or a lower alkyl radical, as well as physiologically compatible salts, esters and amides thereof, exhibit hypoglycaemic and hypolipidaemic activity.
公式为##STR1##的苯基-烷基-羧酸,其中A为一芳基、芳基烷基或芳基乙烯基基团,可选择性地被羟基、卤素、三氟甲基、烷基、烷硫基、烷氧基、烯氧基、烷氧基烷基、烷基取代的氨基、芳氧基或烷氧基取代的芳氧基取代,或为芳氧基烷基或芳硫基烷基基团,或可选择性地被卤素、烷基或烷氧基取代的杂环环系统;Y为一个价键或一个含有最多3个碳原子的直链或支链低级烷基基团;X为一直链或支链、饱和或不饱和的双价脂肪族碳氢基团,含有2到8个碳原子,苯环和羧基之间至少有2个碳原子;R为氢原子或低级烷基基团。以及其生理兼容的盐、酯和酰胺具有降血糖和降血脂活性。